Font Size:
a
A
A
Keyword [Hodgkin lymphoma]
Result: 41 - 60 | Page: 3 of 10
41.
Variabilities Of Serum Proteomic Spectra In Patients With Non-hodgkin Lymphoma
42.
Interaction Between HRS And Tumor-infiltrating CD4~+T Cells In CHL
43.
NI Regimen For The Treatment Of Refractory And Relapsing Non-Hodgkin Lymphoma(NHL)
44.
Survival Analysis Of Primary Gastric Non-Hodgkin Lymphoma
45.
Clinical Study Of FND And CHOP Chemotherapy For Indolent Non-Hodgkin Lymphoma Patients
46.
The Research On Expression Of Relative Immunomarkers In Neoplastic Cells And Background Cells Of Classical Hodgkin Lymphoma
47.
The Expression Of Hyaluronan In Human Non-Hodgkin-Lymphoma And Its Effects On CEM Cell Proliferation And Invasiveness
48.
Primary Thyroid Lymphoma: Clinical Study Of 12 Cases And Review Of The Literature
49.
Management Of Adrenal Non-Hodgkin Lymphoma (Report Of 4 Cases)
50.
Righting Cancer Side In Combination With Chop Regimen In The Treatment Of Non-hodgkin's Lymphoma Clinical Observation
51.
Detection Of Bcl-2/IgH And IgH Rearrangements In Peripheral And Bone Marrow Lymphocytes Of The Patients With Non-Hodgkin Lymphoma
52.
Expression And Clinical Significances Of Hedgehog Signaling Pathway In Non-Hodgkin's Lymphoma
53.
The Effect Of Thalidomide On Serum VEGF In Patientswith Non-hodgkin Lymphoma And Their Clinical Significance
54.
The Mechanisms Of CD99 Regulation On MiR-9/PRDM1 Inducing Redifferentiation Of H/RS Cells
55.
Expression And Significance Of Circulating Endothelial Progenitor Cells In Non-Hodgkin Lymphoma
56.
Genetic Variations Associated With Colorectal Cancer And Non-Hodgkin Lymphoma Susceptibility And Adverse Events In Rectal Cancer Patients Treated With Adjuvant Concurrent Chemoradiotherapy
57.
Combating Non-hodgkin Lymphoma By Targeting Both CD20and HLA-DR Through CD20-243CrossMab
58.
Clinical Studies Of Non-Hodgkins Lymphoma
59.
Analysis Of Primary Extranodal Non-Hodgkin Lymphomas Of The Oral Cavity
60.
18
F-FDG PET-CT Application In Lymphoma
<<First
<Prev
Next>
Last>>
Jump to